Expert Interviews

Thought-provoking interviews with industry experts on topics critical to the diagnosis, treatment, and prevention of progressive eye health

Aerie continues COMET program to study treatment of dry eye

October 21, 2022

Michelle Senchyna, PhD, provided an update of the COMET program and other development activities at Aerie Pharmaceuticals during a conversation at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago.

Update on TENAYA and LUCERENE clinical trials

October 21, 2022

During a conversation at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago, Rishi Singh, MD, offered highlights of the two-year results of faricimab in a pair of phase 3 clinical trials.

ARMOR study can offer starting point for treatment of patients with serious eye infections, corneal ulcers

October 20, 2022

According to Penny Asbell, MD, FACS, MBA, the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study has identified high levels of in vitro antibiotic resistance among ocular staphylococcal and pneumococcal pathogens, resistance that may affect treatment success. She discussed the program at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago.

Durezol studied as treatment option for scleritis

October 15, 2022

Meghan Berkenstock, MD, presented a paper at AAO titled “Effectiveness of Durezol as Additional Agent to Systemic Medications for Treatment of Scleritis,” and shared the highlights in a conversation with Ophthalmology Times.®